ARCHIVES

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

This article is from The Cancer Letter archive.

Vol. 25 No. 21 | May 28, 1999

Download PDF Visit The Full Archive

Related Articles

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

Obituary: Joan Mauer, 65, Chief, NCI Clinical Trials Monitoring Branch

October 15, 2010

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976

Clinton Signs Bill Creating NIH Center On Minority Health.

December 1, 2000

NCI Is Convinced It Has Isolated Human Cancer Virus

February 14, 1975

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002